Open AccessSurveillance and delivery tactics for women with brain tumors
Author(s) -
Z. Sh. Gilyazutdinova
Publication year - 1989
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj99735
Subject(s) - pregnancy , medicine , brain tumor , placenta , stimulant , hormone , obstetrics , fetus , pathology , biology , genetics
Pregnancy in women with brain tumors is extremely dangerous, and the maternal mortality rate is 24.3%. In 75% of cases, intracranial tumors develop in women of reproductive age and may first become apparent during pregnancy. This is due to fluid retention in pregnant women. We assume that tumor growth during pregnancy is associated with significant metabolic, particularly neuroendocrine changes in pregnant women; even the placenta as a powerful hormonal organ may be a stimulant, tumor growth.